Marc Vervloet is nephrologist, professor of Nephrology and co-directing the Nephrology research program, at the Amsterdam University Medical Center, Amsterdam, The Netherlands. He is research program leader at the Institute Amsterdam Cardiovascular Sciences (ACS) chair of the CKD-Mineral and Bone Disorders (CKD-MBD) working group of the ERA (European Renal Association), member of the scientific committee of the Dutch Kidney Foundation and member of the KDIGO committee on CKD-MBD. Dr Vervloet gained his medical degree in 1989, graduated as internist in 1997 and as nephrologist in 1999. His thesis encompassed research on the deranged metabolism of minerals and bone in chronic kidney disease. His clinical work is related to CKD and he is heading the haemodialysis unit at his hospital. He is teaching both medical students, residents, and nephrology fellows, and is guiding several PhD students. His research mainly covers topics related on CKD-MBD, in particular on the role of cardiovascular disease, vascular calcification, FGF23, Klotho, the clinical use of calcimimetic therapy, and phosphate and magnesium control. In addition, he is studying CKD-associated pruritus. The basic research he is conducting, comprises several animal models of CKD, vitamin D deficiency, using mainly cardiovascular endpoint, both in terms of imaging and functional testing in vivo. He is theme editor of Nephrology Dialysis and Transplantation.